Crying in O.Y.

Torriden at 100B Won: LG H&H Signals & Indie Consolidation


Listen Later

Host Zac returns to the "Crying in Olive Young" studio to dissect the success of Torriden, a brand that has mastered the middle ground between "Clean Beauty" and "Dermacosmetics."

With the Dive-In Low Molecular Hyaluronic Acid Serum reaching 11 million units sold as of 2025, Torriden isn't just a trend—it's a category leader. We explore the "5-D Complex" technology that makes their HA serum a global bestseller at Sephora and Boots, and why it consistently tops the Olive Young charts.

The Business Sidebar: We address the rumors surrounding LG Household & Health Care (LG H&H) and their interest in the indie market. What does CEO Lee Sun-Joo’s "Agile Adaptation" strategy mean for the future of K-Beauty? Plus, we provide an essential update on Dr. Althea’s recent press release regarding their 2026 expansion and internal sale discussions.

Key Highlights:

  • Torriden’s "Your Skin is Our Planet" ethos.

  • The math behind a 100-billion-won brand.

  • Hyaluronic Acid: Molecular weights explained.

  • LG H&H’s shift away from legacy brands toward indie prospects.

  • Dr. Althea’s 2026 recruitment and growth update.

Connect with us:IG: @CryingInOliveYoungKorean Language K-Beauty Updates: @Goojeon

...more
View all episodesView all episodes
Download on the App Store

Crying in O.Y.By Zac